Imagine a world where millions of people struggle with high cholesterol, a silent threat that fuels heart disease, yet many cannot tolerate standard treatments like statins due to side effects or poor response, leaving them at risk. This pressing challenge affects countless lives, with
Imagine a world where a cancer diagnosis no longer carries the weight of uncertainty, where treatments are tailored to the unique makeup of each patient, and where technology detects the disease before symptoms even appear. This vision is rapidly becoming reality as oncology undergoes a profound
Understanding which hospitalized patients with cirrhosis face the highest risk of mortality is a pressing challenge in modern healthcare. Years of research and development have culminated in an AI model designed to accurately predict mortality risk for these patients, significantly aiding
In the rapidly evolving field of cancer epidemiology, understanding how race and ethnicity interact with cancer incidence and mortality is crucial. Ivan Kairatov, a biopharma expert with a strong background in research and development, sheds light on the implications of changing race data
India's healthcare landscape is experiencing transformative changes with recent advancements, including the inauguration of the Phenome India "National Biobank." This ambitious initiative, spearheaded by Dr. Jitendra Singh, underscores a pivotal moment for personalized healthcare in the country.
In the evolving landscape of healthcare, seamless integration between payers and providers is not just a trend but a necessity for enhancing patient care and provider engagement. Fragmented and isolated data have long been challenges that hinder timely and informed decision-making in the medical
